相关实验视频
Updated: Jun 8, 2025

05:50
Ameliorating Osteoarthritis in Mice Using Silver Nanoparticles
Published on: June 2, 2023
1.1K
一个具有增强滑和抗炎性能的核心刷纳米平台,用于骨关节炎治疗
Yingying Liu1,2, Zhiyan Ma2,3, Xin Wang1,4
1Biomedical Sciences College, Shandong Medicinal Biotechnology Centre, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, Shandong, 250117, China.
Advanced science (Weinheim, Baden-Wurttemberg, Germany)
|November 1, 2024
概括
一个新的纳米平台SiO2@PP-Cur通过改善关节滑和减少炎症来增强骨关节炎 (OA) 治疗. 这种核心刷结构促进了软骨的修复,并抑制了OA的进展,提供了一个新的治疗策略.
科学领域:
- 生物材料科学 生物材料科学
- 纳米技术纳米技术
- 类风湿病学 类风湿病学
背景情况:
- 骨关节炎 (OA) 是一种关节疾病,其特征是增加摩擦和炎症,通常涉及M1巨细胞的透.
- 目前的治疗方法旨在改善滑和减少炎症,以修复关节的微环境.
研究的目的:
- 设计和评估一个多功能核心刷纳米平台,用于增强骨关节炎治疗.
- 在OA大鼠模型中研究SiO2@PP-Cur纳米平台的治疗潜力.
主要方法:
- 一个核心刷纳米平台 (SiO2@PP-Cur) 被合成,其中包括一个ROS清理核心和一个加载黄素的滑增强PMPC刷.
- 纳米平台的滑性和抗炎作用在单酸诱导关节炎 (MIA) 的老鼠模型中进行了评估.
主要成果:
- SiO2@PP-Cur纳米平台创建了一个水化层,增强滑性并减少关节磨损.
- 内关节注射通过Nrf2激活促进M1到M2巨细胞两极分化,有效缓解炎症.
- 软骨退化被减弱,关节的微环境被改造为一个亲再生状态.
结论:
- SiO2@PP-Cur纳米平台显示出抑制OA进展的巨大潜力.
- 这项研究提出了一种新的战略,用于开发先进的核心刷纳米平台,用于有效的OA治疗.
相关概念视频
Analgesia and Pain Management
525
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
525
Knee Joint
1.5K
The knee joint is the most complicated joint in the body. It consists of three articulations– two tibiofemoral and one patellofemoral. As is characteristic of synovial joints, the knee joint has a thin articular capsule that partially surrounds this joint cavity. Additionally, several ligaments, muscles, and cartilaginous structures support the movement of the knee.
A total of seven ligaments support the knee joint. The patellar ligament, which is also attached to the quadriceps femoris...
A total of seven ligaments support the knee joint. The patellar ligament, which is also attached to the quadriceps femoris...
1.5K
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
97
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
97
Drugs for Treatment of Ulcerative Colitis in IBD
124
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
124
Inflammatory Response II: Inflammatory Exudate and Tissue Repair
4.8K
The immune system's inflammatory response destroys the invading pathogen, permitting the tissue to heal. The changes during the cellular and vascular stages allow exudate formation at the site of inflammation. The inflammatory exudate released from the wound has high protein content and a specific gravity above 1.020.
The typical wound exudate is odorless, transparent, straw-colored, thin, and watery. Exudate, however, can differ depending on the state of wound healing. Likewise, the...
The typical wound exudate is odorless, transparent, straw-colored, thin, and watery. Exudate, however, can differ depending on the state of wound healing. Likewise, the...
4.8K
Inflammatory Bowel Disease IV: Pharmacological Management
116
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
116

